Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases
Open Access
- 3 May 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 519
Abstract
For decades, low- and moderate dose radiation therapy has been shown to exert a beneficial therapeutic effect in a multitude of non-malignant conditions including painful degenerative muscoloskeletal and hyperproliferative disorders. Dupuytren and Ledderhose diseases are benign fibroproliferative diseases of the hand/foot with fibrotic nodules and fascial cords, which determine debilitating contractures and deformities of fingers/toes while keloids are exuberant scar formations following burn damage, surgery and trauma. Although radiation therapy has become an established and effective option in the management of these diseases, experimental studies to illustrate cellular composites and factors involved remain to be elucidated. More recent findings, however, indicate the involvement of radiation sensitive targets like mitotic fibroblasts/myofibroblasts as well as inflammatory cells. Radiation-related molecular mechanisms affecting these target cells include the production of free radicals to hamper proliferative activity and interference with growth factors and cytokines. Moreover, an impairment of activated immune cells involved in both, myofibroblast proliferative and inflammatory processes may further contribute to the clinical effects. We here aim at briefly describing mechanisms contributing to a modulation of proliferative and inflammatory processes and to summarize current concepts of treating hyperproliferative diseases by low and moderate doses of ionizing radiation.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (02NUK017A, 02NUK017D, 02NUK017F, 02NUK017G)
- Deutsche Forschungsgemeinschaft (Research training group GRK1657)
- European Commission (604984)
This publication has 118 references indexed in Scilit:
- Immunomodulatory Properties and Molecular Effects in Inflammatory Diseases of Low-Dose X-IrradiationFrontiers in Oncology, 2012
- Dupuytren's: a systems biology diseaseArthritis Research & Therapy, 2011
- Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblastsFibrogenesis & Tissue Repair, 2011
- Feedback between p21 and reactive oxygen production is necessary for cell senescenceMolecular Systems Biology, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Differential Gene Expression Analysis of Subcutaneous Fat, Fascia, and Skin Overlying a Dupuytren's Disease Nodule in Comparison to Control TissueHAND, 2009
- Epidemiological Evaluation of Dupuytren's Disease Incidence and Prevalence Rates in Relation to EtiologyHAND, 2009
- The MyofibroblastThe American Journal of Pathology, 2007
- Epithelial Origin of Myofibroblasts during Fibrosis in the LungProceedings of the American Thoracic Society, 2006
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002